Santa Cruz Biotechnology offers a broad range of Salmonella O Antibodies for researching Salmonella infections and their mechanisms. Salmonella O Antibodies are compatible with multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Salmonella O Antibodies target the O antigen component of the lipopolysaccharide found on the surface of Salmonella bacteria, which plays a crucial role in the organism's virulence and immune evasion. Understanding the function of the O antigen is essential for developing effective vaccines and therapeutic strategies against Salmonella infections, which pose significant public health challenges worldwide. Salmonella O Antibodies enable researchers to investigate bacterial surface structures and their interactions with host immune systems. The O antigen's role in bacterial survival and pathogenesis makes it a key target for understanding infection mechanisms. Advanced research techniques using Salmonella O Antibodies help identify potential therapeutic targets and vaccine candidates. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of Salmonella infections and developing new treatment strategies.